secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001104659-24-041558
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elanco appoints two directors, reaches cooperation agreement with Ancora
------------------------------------------------------------------------

- Appointed Kathy Turner and Craig Wallace to the Board effective March 29, 2024; Board size increased from 12 to 14.
- Turner and Wallace join the renamed Finance, Strategy and Oversight Committee.
- Cooperation Agreement with Ancora includes standstill, voting commitments, and non-disparagement provisions.
- Turner held senior roles at IDEXX and Abbott; Wallace has 30+ years at Fort Dodge, Trupanion, and Ceva.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465924041558/0001104659-24-041558-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465924041558/tm245182d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-041558

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer